Devoted Health is in talks to raise capital at a $25 billion valuation, a 56 percent jump from the $16 billion price tag attached to its round earlier this year, according to people familiar with the matter. The Medicare Advantage startup's rapid re-pricing underscores how aggressively investors are bidding for companies that pair insurance risk with proprietary AI.
The valuation jump
The $9 billion increase in implied equity value comes just months after the last close. The source did not disclose the size of the new round, the consideration mix, or any break-fee terms. A company spokesperson declined to comment on capital-raising activity.
Membership growth
Devoted ended January with 466,000 members, up 121 percent year over year. Revenue comes almost entirely from government-paid Medicare Advantage premiums, making the business part insurer, part care-delivery vehicle. The model lives or dies on the spread between those fixed premiums and the cost of medical services Orinoco helps manage.
The AI premium
Investors including Andreessen Horowitz, Venrock, General Catalyst, Iconiq, and Emerson Collective are betting that Orinoco, the Parks' proprietary coordination engine, can bend the cost curve enough to justify a valuation that now exceeds several publicly traded managed-care peers on a per-member basis. Medicare Advantage enrollment has more than doubled over the past decade, a tailwind the market is pricing as structural rather than cyclical.
What to watch
The next test is whether the back-to-back rounds reflect durable scaling economics or a momentum trade. Devoted has not filed public financials; the $25 billion figure rests on private negotiations whose terms remain undisclosed. If the round closes at that level, the Parks will have compounded paper value faster than most venture-backed insurers have grown book value.